{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T18:31:37Z","timestamp":1776709897487,"version":"3.51.2"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004770","name":"Universit\u00e0 degli Studi di Parma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004770","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Pheochromocytoma (PHEO) clinical manifestations generally mirror excessive catecholamines secretion; rarely the clinical picture may reflect secretion of other hormones. Watery diarrhea, hypokalemia and achlorhydria (WDHA) is a rare syndrome related to excessive secretion of vasoactive intestinal peptide (VIP).<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical Case<\/jats:title><jats:p>A 73-year-old hypotensive man affected by adrenal PHEO presented with weight loss and watery diarrhea associated with hypokalemia, hyperchloremic metabolic acidosis (anion gap 15 mmol\/l) and a negative urinary anion gap. Abdominal computed tomography scan showed a right adrenal PHEO, 8.1\u00a0cm in maximum diameter, with tracer uptake on <jats:sup>68<\/jats:sup>GaDOTA-octreotate positron emission tomography. Metastasis in lumbar region and lung were present. Both chromogranin A and VIP levels were high (more than10 times the normal value) with slightly elevated urine normetanephrine and metanephrine excretion. Right adrenalectomy was performed and a somatostatin analogue therapy with lanreotide started. Immunostaining showed chromogranin A and VIP co-expression, with weak somatostatin-receptor-2A positivity. In two months, patient clinical conditions deteriorated with severe WDHA and multiple liver and lung metastasis. Metabolic acidosis and hypokalemia worsened, leading to hemodynamic shock and exitus.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>A rare case of WDHA syndrome caused by malignant VIP-secreting PHEO was diagnosed. High levels of circulating VIP were responsible of the rapidly evolving clinical picture with massive dehydration and weight loss along with severe hyperchloremic metabolic acidosis and hypokalemia due to the profuse untreatable diarrhea. The rescue treatment with lanreotide was unsuccessful because of the paucity of somatostatin-receptor-2A on VIP-secreting PHEO chromaffin cells.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2021.652045","type":"journal-article","created":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T10:15:51Z","timestamp":1615976151000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Case Report: Irreversible Watery Diarrhea, Severe Metabolic Acidosis, Hypokalemia and Achloridria Syndrome Related to Vasoactive Intestinal Peptide Secreting Malignant Pheochromocytoma"],"prefix":"10.3389","volume":"12","author":[{"given":"Aurelio","family":"Negro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignazio","family":"Verzicco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Tedeschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Campanini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magda","family":"Zanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Negri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Farnetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Nicoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Palladini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosaria","family":"Santi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Cunzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Calvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Coghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Gerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Volpi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gallia","family":"Graiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aderville","family":"Cabassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1128139","article-title":"The Protean Manifestations of Pheochromocytoma","volume":"41","author":"Manger","year":"2009","journal-title":"Horm Metab Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/0004563217739931","article-title":"Clinical evaluation and treatment of phaeochromocytoma","volume":"55","author":"Davison","year":"2018","journal-title":"Ann Clin Biochem"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.4236\/ijcm.2013.44040","article-title":"Severe ectopic Cushing\u2019s syndrome due to ACTH-secreting pheochromocytoma","volume":"4","author":"Negro","year":"2013","journal-title":"Int J Clin Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002253","article-title":"Concurrent heterozygous Von-Hippel-Lindau and transmembrane-protein-127 gene mutation causing an erythropoietin-secreting pheochromocytoma in a normotensive patient with severe erythrocytosis","volume":"38","author":"Negro","year":"2020","journal-title":"J Hypertens"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(58)90075-5","article-title":"Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia","volume":"25","author":"Verner","year":"1958","journal-title":"Am J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1476-5381.2012.01871.x","article-title":"Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR Review 1","volume":"166","author":"Harmar","year":"2012","journal-title":"Br J Pharmacol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.1998.274.4.G718","article-title":"Dual role of CFTR in cAMP-stimulated HCO3- secretion across murine duodenum","volume":"274","author":"Clarke","year":"1998","journal-title":"Am J Physiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.1997.272.4.G872","article-title":"CFTR mediates cAMP- and Ca2+-activated duodenal epithelial HCO3- secretion","volume":"272","author":"Hogan","year":"1997","journal-title":"Am J Physiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7793.1997.411bb.x","article-title":"A functional CFTR protein is required for mouse intestinal cAMP-, cGMP- and Ca (2+)-dependent HCO3- secretion","volume":"505","author":"Seidler","year":"1997","journal-title":"J Physiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(73)91947-8","article-title":"Vasoactive intestinal peptide and watery-diarrhoea syndrome","volume":"2","author":"Bloom","year":"1973","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1976.tb03828.x","article-title":"Evidence for secretion of vasoactive intestinal peptide by tumours of pancreas, adrenal medulla, thyroid and lung: support for the unifying APUD concept","volume":"5","author":"Said","year":"1976","journal-title":"Clin Endocrinol"},{"key":"B12","unstructured":""},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.51.596.416","article-title":"Watery diarrhoea and hypokalemia associated with a phaechromocytoma","volume":"51","author":"Loehry","year":"1975","journal-title":"Postgrad Med J"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v6.i14.862","article-title":"Octreotide reverses shoch due to vasoactive intestinal peptide-secreting adrenal pheochromocytoma: a case report and review of literature","volume":"6","author":"Hu","year":"2018","journal-title":"World J Clin Cases"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i34.4649","article-title":"Watery diarrhea, hypokalemia and achlorhydria syndrome due to an adrenal pheochromocytoma","volume":"13","author":"Ikuta","year":"2007","journal-title":"World J Gastroenterol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4065\/77.1.97","article-title":"Pheochromocytoma producing vasoactive intestinal peptide","volume":"77","author":"Smith","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4158\/EP14093.CR","article-title":"Malignant pheochromocytoma secreting vasoactive intestinal peptide and response to sunitinib: a case report and literature review","volume":"20","author":"Amit","year":"2014","journal-title":"Endocr Pract"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/BF01314057","article-title":"Watery diarrhea syndrome due to an adrenal pheochromocytoma secreting vasoactive intestinal polypeptide","volume":"30","author":"Sackel","year":"1985","journal-title":"Dig Dis Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-553","article-title":"A rare case of watery diarrhea, hypokalemia and achlorhydria syndrome caused by pheochromocytoma","volume":"14","author":"Jiang","year":"2014","journal-title":"BMC Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.1999.00533.x","article-title":"A patient with neurofibromatosis type 1 and watery diarrhoea syndrome due to a VIP-producing adrenal phaechromocytoma","volume":"246","author":"Quarles Van Ufford Mannesse","year":"1999","journal-title":"J\u00a0Intern Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/sj.jcbfm.9600163","article-title":"Location and function of VPAC1, VPAC2 and NPR-C receptors in VIP-induced vasodilation of porcine basilar arteries","volume":"26","author":"Grant","year":"2006","journal-title":"J Cereb Blood Flow Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12707","article-title":"Neuroendocrine regulation of innate lymphoid cells","volume":"286","author":"Quatrini","year":"2018","journal-title":"Immunol Rev"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1979.237.6.E535","article-title":"Vasoactive intestinal polypeptide in vagally mediated pancreatic secretion of fluid and HCO3","volume":"237","author":"Fahrenkrug","year":"1979","journal-title":"Am J Physiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000069707","article-title":"Schaffalitzky de Muckadell OB. Effect of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on pancreatic, hepatic and duodenal mucosal bicarbonate secretion in the pig","volume":"67","author":"Glad","year":"2003","journal-title":"Digestion"},{"key":"B25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-1-4939-3463-8","article-title":"The use of bedside urinary parameters in the evaluation of Metabolic Acidosis","volume-title":"Metabolic Acidosis","author":"Wesson","year":"2016"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-019-02213-1","article-title":"Hyperchloremia and acute kidney injury: a spurious association or a worrisome reality","volume":"15","author":"Regolisti","year":"2020","journal-title":"Internal Emergency Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00779","article-title":"Electrolyte Disorders Induced by Antineoplastic Drugs","volume":"10","author":"Verzicco","year":"2020","journal-title":"Front Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-010-2045-8","article-title":"Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedside","volume":"16","author":"Levy","year":"2010","journal-title":"Intensive Care Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.114.302849","article-title":"Low serum ferroxidase I activity is associated with mortality in heart failure and related to both peroxynitrite-induced cysteine oxidation and tyrosine nitration of ceruloplasmin","volume":"114","author":"Cabassi","year":"2014","journal-title":"Circ Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"691693","DOI":"10.1155\/2015\/691693","article-title":"Myeloperoxidase-Related Chlorination Activity Is Positively Associated with Circulating Ceruloplasmin in Chronic Heart Failure Patients: Relationship with Neurohormonal, Inflammatory, and Nutritional Parameters","volume":"2015","author":"Cabassi","year":"2015","journal-title":"BioMed Res Int"},{"key":"B31","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1161\/01.HYP.37.2.698","article-title":"Norepinephrine reuptake is impaired in skeletal muscle of hypertensive rats in vivo","volume":"37","author":"Cabassi","year":"2001","journal-title":"Hypertension"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-55330-6_13","article-title":"Mitochondrial Mechanosensor Microdomains in Cardiovascular Disorders","volume":"982","author":"Miragoli","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/BF01852320","article-title":"Effect of vasoactive intestinal polypeptide (VIP) on glucose and lipid metabolism of isolated rat adipocytes","volume":"188","author":"Hauner","year":"1988","journal-title":"Res Exp Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1210\/endo-112-4-1469","article-title":"Effects of porcine intestinal heptacosapeptide and vasoactive intestinal polypeptide on insulin and glucagon secretion in rats","volume":"112","author":"Szec\u00f3wka","year":"1983","journal-title":"Endocrinology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1995.tb01877.x","article-title":"Short-term effects of octreotide on blood pressure and plasma catecholamines and neuropeptide Y levels in patients with phaeochromocytoma: a placebo-controlled trial","volume":"42","author":"Plouin","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2002.01658.x","article-title":"Effects of slow-release octreotide on urinary metanephrine excretion and plasma chromogranin A and catecholamine levels in patients with malignant or recurrent phaeochromocytoma","volume":"57","author":"Lamarre-Cliche","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051682","article-title":"Somatostatin Analogs in Clinical Practice: a Review","volume":"21","author":"Gomes-Porras","year":"2020","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.652045\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T10:15:55Z","timestamp":1615976155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.652045\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,17]]},"references-count":37,"alternative-id":["10.3389\/fendo.2021.652045"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.652045","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,17]]},"article-number":"652045"}}